Brenda Jeglinski

VP Clinical Operations

Brenda Jeglinski joined Boston Pharmaceuticals as Vice President, Head of Clinical Operations in April 2021 with responsibilities for vendor/CRO management and clinical trial management activities. Brenda has 20+ years of experience in Clinical Operations across multiple companies such as Biogen, Ironwood and Verastem Oncology. Brenda has diverse experience in multiple therapeutic areas such as CNS, Dermatology, Gastrointestinal, Hematology, Immunology, Neurology, Oncology, Pulmonary and Respiratory Diseases. Brenda holds a bachelor’s degree from Lesley University.